© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Sydney Jennings
Articles
Telemedicine Boosts Inhaler Technique, QoL After Severe COPD Exacerbations: Daily Dose
November 20, 2025
Your daily dose of the clinical news you may have missed.
Menopause Treatment in Real-World Practice: Ob/Gyn Anna Christine Cochrane, MD Highlights New Research
November 20, 2025
Cochrane shares her own research findings on how clinician specialty shapes menopause care and highlights gaps in hormone therapy prescribing.
Treatment of Vasomotor Symptoms: From Hormone Therapy to Neurokinin Receptor Antagonists
November 20, 2025
Larkin Larkin, MD, reviews treatment options for VMS, comparing hormone therapy effectiveness with antidepressants and new neurokinin antagonists.
Rising Youth Hypertension and Its Long-Term Impact on Coronary Disease: Two New Data Sets
November 20, 2025
A 2-fold rise in pediatric hypertension over 2 decades and new long-term imaging data signal a need to rethink how early clinicians act on elevated BP.
Quadrivalent modRNA Influenza Vaccine Shows Superior Efficacy to Licensed Inactivated Vaccine in Phase 3 Trial
November 20, 2025
Results showed that Pfizer’s mRNA vaccine cut influenza-like illness by 34.5% compared with a standard influenza vaccine.
Dual GCG/GLP-1 Agonist Mazdutide 9 mg Produces 20% Weight Loss in Phase 3 Trial of Chinese Adults with Obesity
November 20, 2025
GLORY-2 participants showed continuous weight loss through 60 weeks with no plateau; mazdutide also improved multiple cardiometabolic markers.
Physical Activity in Mid- and Late Life Linked to Markedly Lower Risk of Dementia
November 19, 2025
Life-course analysis sheds light on how movement patterns influence brain resilience, giving clinicians new context for counseling about dementia prevention.
Weekly Dose Podcast: FDA Breakthrough in Acromegaly, Alcohol–Dementia Risk Clarified, Tirzepatide in Youth T2D, Precision Mood Gains, and Major Contraception Practice Insights
November 19, 2025
Topics include new findings on oral acromegaly therapy, alcohol and dementia risk, tirzepatide in youth T2D, precision mood care, and LARC outcomes.
FDA Clears First CGM-Integrated Basal Insulin Dosing Optimizer for Adults With Type 2 Diabetes
November 19, 2025
FDA approves Dexcom Smart Basal, a groundbreaking CGM-integrated insulin dosing optimizer, enhancing diabetes management for adults with Type 2 diabetes.
Two Alzheimer Disease Therapies to Watch at CTAD 2025: Lecanemab and Sabirnetug Updates
November 19, 2025
Eisai and Acumen Therapeutics will present new data in areas including long-term outcomes, brain delivery strategies, and early-stage Alzheimer disease.